Updated Biosafety Regulation in Cambridge: Good for Research? Good for Business?
Posted on Tue, Jul 27, 2010 @ 08:09 AM
Co-Written by Matt Bauer, Marketing Intern and Kim Parker, Life Sciences Account Manager
The Cambridge Public Health Department has recently revised procedure aimed to make Biosafety regulation more stringent. The Cambridge Biosafety Committee (CBC), which was established to oversee basic scientific research involving recombinant DNA (rDNA), was granted further authority. These revised regulations now require all high-risk labs, even those not involved with rDNA research, to apply through the city for permits as well as allow the Biosafety Committee to perform site visits. Labs used to study agents that pose a high risk of life-threatening disease with no cure known, or Level 4 biohazard labs, were officially banned with this recent Cambridge Regulation. These updates to procedure come after rising health and safety concerns from nearby residents as well as biotech employees.
So why does this regulation matter? Is the stricter regulation impacting your facility and how you do research and business? Triumvirate wants to hear your thoughts!